Roche Holding AG Market Cap 2006-2019 | RHHBY

Roche Holding AG market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Roche Holding AG market cap as of July 31, 2020 is $295.17B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $295.170B $61.869B
Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. The Company distributes its products throughout Europe, the United States, Asia and Latin America.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $383.760B 18.29
Pfizer (PFE) United States $213.750B 13.36
Merck (MRK) United States $202.534B 14.48
Novartis AG (NVS) Switzerland $187.994B 14.62
Novo Nordisk (NVO) Denmark $153.839B 25.62
AstraZeneca (AZN) United Kingdom $146.388B 28.46
Eli Lilly (LLY) United States $143.745B 21.94
AbbVie (ABBV) United States $140.158B 10.20
Sanofi (SNY) $131.342B 15.61
GlaxoSmithKline (GSK) United Kingdom $101.144B 13.26
Bayer (BAYRY) Germany $61.459B 8.76
H Lundbeck (HLUYY) Denmark $7.199B 0.00
Innoviva (INVA) United States $1.372B 6.58